According to Intercept Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 41,792,000. At the end of 2023 the company had 41,792,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 41.79 M | 0.75% |
2022 | 41.47 M | 40.31% |
2021 | 29.56 M | -10.43% |
2020 | 33 M | 0.69% |
2019 | 32.78 M | 10.47% |
2018 | 29.67 M | 18.01% |
2017 | 25.14 M | 1.35% |
2016 | 24.81 M | 1.89% |
2015 | 24.35 M | 13.89% |
2014 | 21.38 M | 10.45% |
2013 | 19.35 M | 27.17% |
2012 | 15.22 M | 357.25% |
2011 | 3.32 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Eli Lilly LLY | 949,379,000 | 2,171.68% | ๐บ๐ธ USA |
Gilead Sciences GILD | 1,248,000,000 | 2,886.22% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,057,000,000 | 4,821.99% | ๐บ๐ธ USA |
MediciNova MNOV | 49,046,246 | 17.36% | ๐บ๐ธ USA |